English | Español
Patient Daily | Apr 19, 2026

Gilead Sciences acquires Tubulis for up to $5 billion in oncology deal
Patient Daily | Apr 19, 2026

Amgen reports positive phase 3 results for subcutaneous Tepezza in thyroid eye disease
Patient Daily | Apr 19, 2026

FDA proposes permanent rare disease vouchers and new clinical trial pathway in 2027 budget
Patient Daily | Apr 19, 2026

Sanofi reports mixed results for lunsekimig in asthma, rhinosinusitis, and eczema trials
Patient Daily | Apr 19, 2026

AbbVie to offer Humira at discounted price on TrumpRx platform
Patient Daily | Apr 19, 2026

CAR T therapy used to treat three autoimmune diseases in single patient
Patient Daily | Apr 19, 2026

FDA seeks expanded authority to regulate postapproval manufacturing changes
Patient Daily | Apr 19, 2026

New blood test detects four cancers and other diseases by filtering healthy DNA

Trending
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures